secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001104659-24-073736
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood shareholders elect nine directors, approve executive pay, ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- All nine director nominees elected with over 130 million votes each for a one-year term.
- Advisory vote on executive compensation passed with ~127.4 million for, ~8.0 million against.
- Ratification of Ernst & Young as auditor for 2024 approved with ~136.8 million for, ~6.3 million against.
- Meeting held June 18, 2024; all proposals received majority support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465924073736/0001104659-24-073736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465924073736/tm2417654d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-073736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer